Advertisement
News
Advertisement

Sanofi-Aventis' Multaq receives European approval

Mon, 11/30/2009 - 3:58am
NEW YORK (AP) — Sanofi-Aventis said Monday its irregular heart rhythm drug Multaq received regulatory approval in the European Union. The European Commission granted approval for the drug, which clears the way for sales in all 27 European member states. The drug is already approved in the U.S.
Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading